Company / Capital Expenditures
PULSE BIOSCIENCES, INC. Capital Expenditures History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Capital Expenditures
$315.0K
FY2025
5-year range
$125.0K / $437.0K
FY2021-FY2025
Trend
+152.0%
vs FY2024
Sector context
#149 of 151
Health Care
What the data says
Among 151 Health Care companies, PULSE BIOSCIENCES, INC. is in the bottom 1% for capital expenditures. Capital Expenditures has fluctuated over the past 10 years, ranging from $64,000 in FY2016 to $3M in FY2017.
Based on SEC 10-K filings.
$315,000 in FY2025 with a 5-year CAGR of -6.5%.
Declined from $401,000 to $315,000 over the past 2 years.
Health Care sector context is included.
Capital Expenditures over time
Growth rates
- 3-Year CAGR
- -7.7%
- 5-Year CAGR
- -6.5%
- 10-Year CAGR
- -
Sector benchmark
Bottom 1% in Health CareTop 99% of 151This company $315.0K Sector average $271.7M
▼
-99.9% below sector average
Key checks
Key Insights
- 5-year CAGR of -6.5%, indicating a declining trend.
- In FY2025, capital expenditures increased 152.0% year-over-year.
- Ranks #149 out of 151 companies in the Health Care sector.
- Peak capital expenditures was recorded in FY2017.
Company context
Key Data Points
- Low Piotroski F-Score: 2/9 (multiple financial health concerns)
- Altman Z-Score -3.66 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Capital ExpendituresValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $315.0K | +152.0% |
| FY2024 | $125.0K | -68.8% |
| FY2023 | $401.0K | +0.0% |
| FY2022 | $401.0K | -8.2% |
| FY2021 | $437.0K | -0.9% |
| FY2020 | $441.0K | -27.5% |
| FY2019 | $608.0K | +120.3% |
| FY2018 | $276.0K | -89.2% |
| FY2017 | $2.6M | +3885.9% |
| FY2016 | $64.0K | -25.6% |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026